BML, Inc.

Equities

4694

JP3799700004

Healthcare Facilities & Services

Delayed Japan Exchange Other stock markets 08:21:12 2024-04-18 pm EDT			5-day change	1st Jan Change
2,924 ^JPY	-0.75%		-5.81%	-2.67%

Mar. 22	Matsa Resources Receives More High-Grade Gold Assays from Devon Pit Mine in Western Australia; Shares Down 3%	MT
Mar. 15	Matsa Resources Secures Water License for Devon Pit Gold Mine; Shares Down 3%	MT

Tranche Update on BML, Inc.'s Equity Buyback Plan announced on February 28, 2022.

April 05, 2022 at 01:00 am EDT

From February 28, 2022 to March 31, 2022, the company has repurchased 235,500 shares, representing 0.58% for ¥751.98 million. With this, the company has completed the repurchase of 235,500 shares, representing 0.58% for ¥751.98 million under the buyback announced on February 28, 2022.

Latest news about BML, Inc.

Matsa Resources Receives More High-Grade Gold Assays from Devon Pit Mine in Western Australia; Shares Down 3%	Mar. 21	MT
Matsa Resources Secures Water License for Devon Pit Gold Mine; Shares Down 3%	Mar. 14	MT
Brightstar Resources Completes Second Gold Pour from Selkirk JV; Shares Up 6%	Mar. 11	MT
Brightstar Resources Rises 7% After Completing First Gold Pour from Selkirk Mining JV	Mar. 07	MT
Matsa Resources Signs Mining Agreement for Western Australian Gold Mine	Mar. 04	MT
Brightstar Resources Concludes Mining Work at Menzies Gold Project in Western Australia	Feb. 28	MT
Auric Mining to Recommence Mining at Western Australia’s Jeffreys Find Gold Mine	Jan. 22	MT
Boab Metals Enters Subscription Agreement with Acuity Capital; Shares Up 3%	Dec. 21	MT
BMO Changes Its Forecasts for Federal Reserve, Bank of Canada Policy Rates	Dec. 18	MT
BMO on The Day, Week Ahead in Canada	Nov. 13	MT
BMO Comments on The Euro After ECB Inflation Survey, Knot Comments	23-10-11	MT
Boab Metals Completes Drilling at Sorby Hills Project; Shares Jump 9%	23-08-29	MT
Brightstar Resources Begins Mining at Menzies Gold Project in Western Australia	23-08-24	MT
Boab Metals Inks Heads of Agreement for New Accommodation Facility in Western Australia's Kununurra	23-07-19	MT
SKY Metals Aims to Sell Galwadgere Project	23-07-14	MT
Auric Mining Nears Maiden Gold Pour at Jeffreys Find Mine	23-07-11	MT
North American Morning Briefing : Tesla Bounce Gives Nasdaq a Boost	23-07-03	DJ
North American Morning Briefing : Chip Stocks Take Beating on Report of China Export Ban	23-06-28	DJ
Astrotech Receives Unsolicited Acquisition Proposal From BML Investment Partners	23-06-28	MT
US Durable Goods Orders Unexpectedly Climb in May, Other Data in Spotlight; US Equity Futures Mixed Premarket	23-06-27	MT
Top Premarket Gainers	23-06-27	MT
Boab Metals Starts Phase Seven Drilling at Sorby Hills Project; Shares Up 6%	23-06-15	MT
Auric Mining Moves Closer to First Gold Pour at Jeffreys Find Project	23-06-13	MT
BML, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
Tranche Update on BML, Inc.'s Equity Buyback Plan announced on February 10, 2023.	23-04-17	CI

Chart BML, Inc.

Duration

Period

More charts

Company Profile

BML, INC. is mainly engaged in the clinical testing as well as related business. The Testing segment engages in the commissioned work of clinical testing. The Medical Information Systems segment is engaged in the manufacturing and sales of system equipment for medical institutions, as well as provision of medical information service.

Sector

Healthcare Facilities & Services

Calendar

2024-05-09 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for BML, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2,946 JPY

Average target price

3,033 JPY

Spread / Average Target

+2.96%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
BML, INC.	-2.67%	746M
SONIC HEALTHCARE LIMITED	-19.17%	8.01B
RADNET, INC.	+36.93%	3.52B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-26.72%	2.98B
SYNLAB AG	-7.36%	2.48B
DR. LAL PATHLABS LIMITED	-12.92%	2.31B
NEOGENOMICS, INC.	-14.89%	1.75B
FLEURY S.A.	-23.12%	1.45B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-39.19%	1.27B
ADICON HOLDINGS LIMITED	-7.98%	1.08B

Medical & Diagnostic Laboratories